TNFα and the TNF receptor superfamily: Structure-function relationship(s)

Microscopy Research and Technique

Volumn 50, Issue 3, 2000, Pages 184-195

  Idriss, Haitham T ^a   Naismith, James H ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Apoptosis; Crystal; Cytokine; Receptor; Structure; TNF

Indexed keywords

AMINO ACIDS; CELL SIGNALING; CRYSTAL STRUCTURE; MACROPHAGES;

CYTOKINES; DIVERSE RANGE; INFLAMMATORY CYTOKINES; MACROPHAGE/MONOCYTE; MEMBRANE RECEPTORS; RECEPTOR; SIGNALING EVENTS; STRUCTURE-FUNCTION RELATIONSHIP; TUMOR NECROSE FACTOR Α; TUMOR NECROSIS FACTORS;

CELL DEATH;

CD27 ANTIGEN; CD40 ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; INFLAMMATION; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0034254453     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H     Document Type: Article

References (116)

1. Acton RD, Dahlberg PS, Uknis ME, Klaerner HG, Fink GS, Norman JG, Dunn DL. 1996. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors. Arch Surg 131:1216-1221.
2. Aggarwal B, Vilcek J, Eds. 1991. Tumor necrosis factors: structure, function and mechanism. Marcel Dekker Publishers, New York.
3. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
4. Armitage RJ. 1994. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 6:407-413.
5. Ashkenazi A, Dixit VM. 1998. Death receptors: signaling and modulation. Science 281:1305-1308.
6. Ashkenazi A, Dixit VM. 1999. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255-260.
7. Baeyens KJ, De Bondt HL, Raeymaekers A, Fiers W, De Ranter CJ. 1999. The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization. Acta Crystallogr D Biol Crystallogr 55:772-778.
8. Baker SJ, Reddy EP. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9.
9. Baker SJ, Reddy EP. 1998. Modulation of life and death by the TNF receptor superfamily. Oncogene 17:3261-3270.
10. Baldwin RL, Stolowitz ML, Hood L, Wisnieski BJ. 1996. Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation. Proc Natl Acad Sci U S A 93:1021-1026.
11. Balkwill FR. 1992. Tumour necrosis factor and cancer. Prog Growth Factor Res 4:121-137.
12. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73:431-445.
13. Bazan JF. 1993. Emerging families of cytokines and receptors. Curr Biol 3:603-606.
14. Bazzoni F, Beutler B. 1996. The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725.
15. Beutler B, Bazzoni F. 1998. TNF, apoptosis and autoimmunity: a common thread? Blood Cells Mol Dis 24:216-230.
16. Beutler BA. 1999. The role of tumor necrosis factor in health and disease. J Rheumatol 26(Suppl) 57:16-21.
17. Beyaert R, Fiers W. 1994. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett 340:9-16.
18. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH, Wallach D. 1995. Self association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and FAS/APOI prompts signalling for TNF and FAS/APO1 effects. J Biol Chem 270:387-391.
19. Brojatsch J, Naughton J, Rolls MM, Zingler K, Young JA. 1996. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87: 845-855.
20. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF. 1993. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-856.
21. Camerini D, Walz G, Loenen WA, Borst J, Seed B. 1991. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol 147:3165-3169.
22. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72:3666-3670.
23. Cha SS, Kim JS, Cho HS, Shin NK, Jeong W, Shin HC, Kim YJ, Hahn JH, Oh BH. 1998. High resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicity. J Biol Chem 273:2153-2160.
24. Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, Shin HC, Sung YC, Oh BH. 1999. 2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11:253-261.
25. Coley WB. 1893. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci 105:487-511.
26. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA. 1994. A lymphotoxin-beta-specific receptor [see comments]. Science 264: 707-710.
27. Czarniecki CW. 1993. The role of tumor necrosis factor in viral disease. Antiviral Res 22:223-258.
28. D'Arcy A, Banner DW, Janes W, Winkler FK, Loetscher H, Schonfeld HJ, Zulauf M, Gentz R, Lesslauer W. 1993. Crystallization and preliminary crystallographic analysis of a TNF-beta-55 kDa TNF receptor complex. J Mol Biol 229:555-557.
29. Darnay BG, Aggarwal BB. 1999. Signal transduction by tumor necrosis factor and tumour necrosis factor related ligands and their receptors. Ann Rheum Dis 58:S0-S11.
30. Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG. 1997. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7:813-820.
31. Dembic Z, Loetscher H, Gubler U, Pan YC, Lahm HW, Gentz R, Brockhaus M, Lesslauer W. 1990. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2:231-237.
32. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421-427.
33. Eck MJ, Sprang SR. 1989. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J Biol Chem 264:17595-17605.
34. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR. 1992. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. J Biol Chem 267:2119-2122.
35. Engelmann H, Novick D, Wallach D. 1990. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265:1531-1536.
36. Fiers W. 1991. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199-212.
37. Frank S, Kohler U, Schackert G, Schackert HK. 1999. Expression of TRAIL and its receptors in human brain tumors [published erratum appears in Biochem Biophys Res Commun 1999 May 27;259(1): 230]. Biochem Biophys Res Commun 257:454-459.
38. Goldfeld AE, Tsai EY. 1996. TNF-alpha and genetic susceptibility to parasitic disease. Exp Parasitol 84:300-303.
39. Goldstein P. 1997. Cell death: TRAIL and its receptors. Curr Biol 7:R750-3.
40. Granger GA, Williams TW. 1968. Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature 218:1253-1254.
41. Gray PW, Aggarwal BB, Benton CV, Bringman TS, Henzel WJ, Jarrett JA, Leung DW, Moffat B, Ng P, Svedersky LP, et al. 1984. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 312:721-724.
42. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, Wu Lee YH, Durkop H, Engelmann H, Scheurich P, Wajant H, Strasser A. 1999. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. Embo J 18:3034-3043.
43. Gruss HJ, Dower SK. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85: 3378-3404.
44. Hieber U, Heim ME. 1994. Tumor necrosis factor for the treatment of malignancies. Oncology 51:142-153.
45. Hohmann HP, Remy R, Brockhaus M, van Loon AP. 1989. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 264:14927-14934.
46. Hu FQ, Smith CA, Pickup DJ. 1994. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343-356.
47. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF, Ashkenazi A, de Vos AM. 1999. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4:563-571.
48. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF, Ashkenazi A, de Vos AM. 2000. A unique zinc-binding site revealed by a high resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 39:633-640.
49. Idriss H. 2000. Do TNF α insensitive cancer cells escape α-tubulin nitro-tyrosinylation? Nitric Oxide 4:1-3.
50. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
51. Jones EY, Stuart DI, Walker NP. 1989. Structure of tumour necrosis factor. Nature 338:225-228.
52. Jones EY, Stuart DI, Walker NPC. 1991. Crystal Structure of TNF. In: Aggarwal BB, Vilcek J, editors. Tumor necrosis factors: structure, function and mechanism, Marcel Dekker, Publishers, New York.
53. Kagan BL, Baldwin RL, Munoz D, Wisnieski BJ. 1992. Formation of ion-permeable channels by tumor necrosis factor-alpha. Science 255:1427-1430.
54. Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D. 1995. 2 A crystal structure of an extracellular fragment of human CD40 ligand [erratum appears in Structure 1995 Dec 15;3(12):1426]. Structure 3:1031-1039.
55. Kolls J, Peppel K, Silva M, Beutler B. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer [published erratum appears in Proc Natl Acad Sci USA 1994 Mar 1; 91(5):1979. Proc Natl Acad Sci USA 91:215-219.
56. Krueger JM, Fang J, Taishi P, Chen Z, Kushikata T, Gardi J. 1998. Sleep. A physiologic role for IL-1 beta and TNF-alpha. Ann N Y Acad Sci 856:148-159.
57. Lang F, Lepple-Wienhues A, Paulmichl M, Szabo I, Siemen D, Gulbins E. 1998. Ion channels, cell volume, and apoptotic cell death. Cell Physiol Biochem 8:285-292.
58. Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W. 1990. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-359.
59. Loetscher H, Gentz R, Zulauf M, Lustig A, Tabuchi H, Schlaeger EJ, Brockhaus M, Gallati H, Manneberg M, Lesslauer W. 1991a. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. J Biol Chem 266:18324-18329.
60. Loetscher H, Steinmetz M, Lesslauer W. 1991b. Tumor necrosis factor: receptors and inhibitors. Cancer Cells 3:221-226.
61. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272:25417-25420.
62. Mallett S, Fossum S, Barclay AN. 1990. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes: a molecule related to nerve growth factor receptor. Embo J 9:1063-1068.
63. Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A. 1997. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272:14029-14032.
64. McWhirter SM, Pullen SS, Holton JM, Crute JJ, Kehry MR, Alber T. 1999. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci U S A 96:8408-8413.
65. Mongkolsapaya J, Grimes JM, Chen N, Xu XN, Stuart DI, Jones EY, Screaton GR. 1999. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat Struct Biol 6:1048-1053.
66. Montgomery RI, Warner MS, Lum BJ, Spear PG. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
67. Naismith JH, Sprang SR. 1998. Modularity in the TNF-receptor family. Trends Biochem Sci 23:74-79.
68. Naismith JH, Devine TQ, Brandhuber BJ, Sprang SR. 1995. Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J Biol Chem 270:13303-13307.
69. Naismith JH, Devine TQ, Kohno T, Sprang SR. 1996. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4:1251-1262.
70. Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K. 1998. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253:395-400.
71. Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, Moraca R, Migliorati G, Riccardi C. 1997. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci U S A 94:6216-6221.
72. Orlinick JR, Chao MV. 1998. TNF-related ligands and their receptors. Cell Signal 10:543-551.
73. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. 1997a. An antagonist decoy receptor and a death domain-containing receptor for TRAIL [see comments]. Science 277:815-818.
74. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. 1997b. The receptor for the cytotoxic ligand TRAIL. Science 276:111-113.
75. Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM. 1998a. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431:351-356.
76. Pan G, Ni J, Yu G, Wei YF, Dixit VM. 1998b. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett 424:41-45.
77. Pearson RB, Kemp BE. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs:tabulations. Methods Enzymol 200:62-81.
78. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV. 1984. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724-729.
79. Peppel K, Crawford D, Beutler B. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174:1483-1489.
80. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A. 1998. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699-703.
81. Pocsik E, Duda E, Wallach D. 1995. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. J Inflamm 45:152-160.
82. Pullen SS, Labadia ME, Ingraham RH, McWhirter SM, Everdeen DS, Alber T, Crute JJ, Kehry MR. 1999. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization [In Process Citation]. Biochemistry 38:10168-10177.
83. Radeke HH, Meier B, Topley N, Floge J, Habermehl GG, Resch K. 1990. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int 37:767-775.
84. Reed C, Fu ZQ, Wu J, Xue YN, Harrison RW, Chen MJ, Weber IT. 1997. Crystal structure of TNF-alpha mutant R31D with greater affinity for receptor R1 compared with R2. Protein Eng 10:1101-1107.
85. Remy I, Wilson IA, Michnick SW. 1999. Erythropoietin receptor activation by a ligand-induced conformation change. Science 283:990-993.
86. Ryffel B, Mihatsch MJ. 1993. TNF receptor distribution in human tissues. Int Rev Exp Pathol 34 Pt B:149-156.
87. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H, et al. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370.
88. Schoenfeld HJ, Poeschl B, Frey JR, Loetscher H, Hunziker W, Lustig A, Zulauf M. 1991. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. J Biol Chem 266:3863-3869.
89. Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A 94:4615-4619.
90. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. 1990. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171:35-47.
91. Shalaby MR, Sundan A, Loetscher H, Brockhaus M, Lesslauer W, Espevik T. 1990. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J Exp Med 172:1517-1520.
92. Shoham S, Davenne D, Cady AB, Dinarello CA, Krueger JM. 1987. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 253:R142-149.
93. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density [see comments]. Cell 89:309-319.
94. Singh J, Garber E, Van Vlijmen H, Karpusas M, Hsu YM, Zheng Z, Naismith JH, Thomas D. 1998. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci 7:1124-1135.
95. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023.
96. Smith CA, Hu FQ, Smith TD, Richards CL, Smolak P, Goodwin RG, Pickup DJ. 1996. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 223:132-147.
97. Smith RA, Baglioni C. 1987. The active form of tumor necrosis factor is a trimer. J Biol Chem 262:6951-6954.
98. Smith RA, Baglioni C. 1992. Characterization of TNF receptors. Immunol Ser 56:131-147.
99. Sprang SR, Eck MJ. 1991. The structure of tumor necrosis factor: perspectives on biological activity. In: Beutler B, editor. The tumor necrosis factors. The molecules in their emerging role in medicine. New York: Raven Press.
100. Spriggs DR, Deutsch S, Kufe DW. 1992. Genomic structure, induction, and production of TNF-alpha. Immunol Ser 56:3-34.
101. Steinshamn S, Bemelmans MH, van Tits LJ, Bergh K, Buurman WA, Waage A. 1996. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J Immunol 157:2155-2159.
102. Steller H. 1995. Mechanisms and genes of cellular suicide. Science 267:1445-1449.
103. Takahashi N, Udagawa N, Suda T. 1999. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 256:449-455.
104. Thoma B, Grell M, Pfizenmaier K, Scheurich P. 1990. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 172:1019-1023.
105. Thornberry NA, Lazebnik Y. 1998. Caspases: enemies within. Science 281:1312-1316.
106. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K. 1997. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142.
107. Van Arsdale TL, Van Arsdale SL, Force WR, Walter BN, Mosialos G, Kieff E, Reed JC, Ware CF. 1997. Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB. Proc Natl Acad Sci U S A 94:2460-2465.
108. Van Linden AA, Cottin V, Leu C, Riches DW. 2000. Phosphorylation of the membrane proximal region of tumor necrosis factor receptor CD120a (p55) at ERK consensus sites. J Biol Chem 275:6996-7003.
109. Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W. 1993. Human TNF mutants with selective activity on the p55 receptor [see comments]. Nature 361:266-269.
110. Vilcek J, Lee TH. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266: 7313-7316.
111. Vinay DS, Kwon BS. 1999. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells. Cell Immunol 192:63-71.
112. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. Embo J 16:5386-5397.
113. Watts AD, Hunt NH, Hambly BD, Chaudhri G. 1997. Separation of tumor necrosis factor alpha isoforms by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 18:1086-1091.
114. Watts AD, Hunt NH, Wanigasekara Y, Bloomfield G, Wallach D, Roufogalis BD, Chaudhri G. 1999. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'. Embo J 18:2119-2126.
115. Wride MA, Sanders EJ. 1995. Potential roles for tumour necrosis factor alpha during embryonic development. Anat Embryol (Berl) 191:1-10.
116. Yuan J. 1997. Transducing signals of life and death. Curr Opin Cell Biol 9:247-251.